← All trials
NCT00600106
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 31, 1999
- Primary completion
- May 31, 2003
- Completion date
- Mar 31, 2010
- First posted
- Jan 24, 2008
- Last posted
- Apr 24, 2019
- Enrollment
- 37
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Cedars-Sinai Medical CenterLead sponsor
- Cedars-Sinai Medical CenterReponsible party - principal investigator
- Cedars-Sinai Medical CenterStudy chair
- Johns Hopkins UniversityCollaborator
- Johns Hopkins UniversityOverall official - principal investigator
- University of Alabama, BirminghamCollaborator
- University of Alabama, BirminghamOverall official - principal investigator
- University of FloridaCollaborator
- University of FloridaOverall official - principal investigator
- University of PittsburghCollaborator
- University of PittsburghOverall official - principal investigator
- Cedars-Sinai Medical CenterSponsor investigator
- University of FloridaOfficial
- Parke-DavisOfficial
- University of PittsburghOfficial
- Cedars-Sinai Medical CenterOfficial
- Parke-DavisCollaborator
- Johns Hopkins UniversityOfficial
- University of Alabama, BirminghamOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.